• 1
    Knutson KL, Lauderdale DS. Sleep duration and overweight in adolescents: self-reported sleep hours versus time diaries. Pediatrics 2007; 119: 1056-1062.
  • 2
    Javaheri S, Storfer-Isser A, Rosen CL, et al. Sleep quality and elevated blood pressure in adolescents. Circulation 2008; 118: 1034-1040.
  • 3
    Patel SR, Malhotra A, White DP, et al. Association between reduced sleep and weight gain in women. Am J Epidemiol 2006; 164: 947-954.
  • 4
    Gutierrez DA, Puglisi MJ, Hasty AH. Impact of increase adipose tissue mass on inflammation, insulin resistance and dyslipidemia. Curr Diab Rep 2009; 9: 26-32.
  • 5
    Kobalava ZD, Villeval de SV, Isikova KV. The role of adiponectin in development and progression of cardiovascular diseases. Kardiologia 2009; 49: 51-58.
  • 6
    Shamsuzzaman ASM, Caples SM, Somers VK. Sleep deprivation and circulatory control. Sleep 2003; 26: 934-936.
  • 7
    Everson CA, Laatsch CD, Hogg N. Antioxidant defense responses to sleep loss and sleep recovery. Am J Physiol Regul Integr Comp Physiol 2005; 288: 374-383.
  • 8
    Lohmeier TE, Hildebrandt DA, Warren S, et al. Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integ Comp Physiol 2005; 288: 828-836.
  • 9
    Lohmeier TE, Barrett AM, Irwin ED. Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension? Curr Hypertens Rep 2005; 7: 193-198.
  • 10
    Benca RM, Schenck CH. Sleep and eating disorders. In: Kryger MH, Roth T, Dement WC, editors. Principles and practices of sleep medicine. Philadelphia: Elsevier, 2005, pp 1337-1344.
  • 11
    Lima DC, Silveira AS, Haibara AS, et al. The enhanced hyperglycemic response to hemorrhage hypotension in obese rats is related to an impaired baroreflex. Metab Brain Dis 2008; 23: 361-373.
  • 12
    Kaye DM, Esler MD. Autonomic control of the aging heart. Neuromolecular Med 2008; 10: 179-186.
  • 13
    Di Nardo F, Burattini R, Cogo CE, et al. Age-related analysis of insulin resistance, body weight and arterial pressure in the Zucker fatty rat. Exp Physiol 2009; 94: 162-168.
  • 14
    Johnson FK, Johnson RA, Durante W, et al. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: 601-608.
  • 15
    Argilés, JM. The obese Zucker rat: a choice for fat metabolism. Prog Lipid Res 1989; 28: 53-66.
  • 16
    Bray GA. The Zucker-fatty rat: a review. Federation Proc 1977; 36: 148-153.
  • 17
    Andersen ML, D'Almeida V, Ko GM, et al. Princípios éticos e práticos do uso de animais de laboratório. São Paulo: Universidade Federal de São Paulo, 2004, pp 18-33.
  • 18
    Papale LA, Paul KN, Sawyer NT, et al. Dysfunction of the Scn8a voltage-gated sodium channel alters sleep architecture, reduces diurnal corticosterone levels, and enhances spatial memory. J Biol Chem 2010; 285: 16553-16561.
  • 19
    Antunes IB, Andersen ML, Baracat EC, et al. The effects of paradoxal sleep deprivation on estrous cycles of the female rats. Horm Behav 2006; 49: 433-440.
  • 20
    Hofmann KL, Mussgay L, Ruddel H. Autonomic cardiovascular regulation in obesity. J Endocrinol 2000; 164: 59-66.
  • 21
    Hubert HB, Feinleib M, MacNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
  • 22
    Hirsch J, Leibel R, Mackintosh R, et al. Heart rate variability as a measure of autonomic function during weight change in humans. Regul Int Compreh Physiol 1991; 30: 1418-1423.
  • 23
    Jin X, Fukuda N, Su J, et al. Effects of leptin on endothelial function with OB-Rb gene transfer in Zucker fatty rats. Atherosclerosis 2003; 169: 225-233.
  • 24
    Rivera L, Morón R, Zarzuelo A, et al. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009; 77: 1053-1063.
  • 25
    Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14: 103S-115S.
  • 26
    Van Dijk G, Thiele TE, Donahey JC, et al. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol Regul Integr Comp Physiol 1996; 27: R1096-R1100.
  • 27
    Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46: 2040-2043.
  • 28
    Grassi G. Leptin, sympathetic nervous system, and baroreflex function. Curr Hypertens 2004; 6: 236-240.
  • 29
    Copinschi G. Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol 2005; 6: 341-347.
  • 30
    Laposky AD, Bradley MA, Williams DL, et al. Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 2008; 295: 2059-2066.
  • 31
    Beccuti G, Pannain S. Sleep and obesity. Curr Opin Clin Nutr Metab Care 2011; 14: 402-412.
  • 32
    Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004; 1: e62.
  • 33
    Gangwisch JE, Malaspina D, Boden-Albala B, et al. Inadequate sleep as a risk factor for obesity: analyses of the NHANES. Sleep 2005; 28: 1289-1296.
  • 34
    Chaput JP, Brunet M, Tremblay A. Relationship between short sleeping hours and childhood overweight/obesity: results from the ‘Quebec en Forme’ Project. Int J Obes 2006; 30: 1080-1085.
  • 35
    Méier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reative protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004; 43: 678-683.
  • 36
    Esler M, Straznicky N, Eikelis N, et al. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48: 1-10.
  • 37
    Mortara A, Rovere MTL, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure. Circulation 1997; 96: 3450-3458.
  • 38
    Head GA, Adams MA. Characterization of the baroreceptor heart rate reflex during development in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1992; 19: 587-597.
  • 39
    Lohmeier TE, Dwyer TM, Irwin ED, et al. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 2007; 49: 1307-1314.